More Business Wire
View Older Stories View Newer Stories-
New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings
-
UL Solutions Opens Ningbo Retail and Consumer Products Laboratory to Help Manufacturers Advance Quality and Safety
-
Xcellbio Announces Partnership with Planet Innovation to Develop and Manufacture Next Generation Instruments to Improve potency for Rapid Cell Therapy Manufacturing
-
DoubleU Games Completes Acquisition of Turkish studio Paxie Games “Secures New Global Growth Engine”
-
Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow
-
ARC Tampa Development Announces Tampa’s New $675 Million Hotel ORA + Private Residences Sold out Phase One in 40 Days – Over $84 Million in Sales
-
StandardAero Announces Pricing of Its Upsized Secondary Offering of 36,000,000 Shares of Common Stock by Affiliates of The Carlyle Group Inc. and GIC Private Limited
-
KBRA Assigns Preliminary Ratings to TierPoint Issuer LLC, Series 2025-1 and Series 2025-2
-
Government of Guyana, Mount Sinai Health System and Hess Corporation Announce Five-Year Extension of National Healthcare Initiative
-
Cemex showcases significant operational and sustainability advancements in its 2024 Integrated Report
-
Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older
-
KBRA Assigns Preliminary Ratings to BRAVO Residential Funding Trust 2025-NQM3 (BRAVO 2025-NQM3)
-
Old El Paso Brings the Heat with New Birria Taco Kit, Breakfast Taco Kit and Expanded Carb Advantage Line
-
Watts Named on TIME’s List of America’s Top GreenTech Companies 2025
-
Loomis Sayles Celebrates 5-Year Anniversary of Growth Equity Strategies Team’s International Growth Strategy
-
United Rentals Selected as One of America’s Best-Managed Companies
-
FORE Biotherapeutics to Present Two Plixorafenib Abstracts at the American Association for Cancer Research Annual Meeting 2025
-
Exelixis to Present Positive Preclinical Data Across Its Pipeline Portfolio for Advanced Cancers at AACR 2025
-
Shadow Power Announces OpenADR 2.0b Compliance
-
Schrödinger to Present Preclinical Data at AACR Annual Meeting
-
CORRECTING and REPLACING Intellinetics Grows 2024 Full-Year Revenues 7%
-
VIQ Solutions to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, March 28, 2025
-
Underwood Law Says Anti-Trust Case Could Benefit Millions of Families Whose Children Participate in Competitive Cheerleading
-
Pioneer Closed-End Funds Announce Postponement of March 26, 2025 Special Meeting of Stockholders
-
Benson Hill Receives Court Approval of First-Day Motions to Support Ongoing Operations During Chapter 11 Process
-
CDR-Life Demonstrates Commitment to Differentiated Pipeline with New Autoimmune Candidate CDR111
-
KaliVir Immunotherapeutics Announces Details of Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting
-
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025
-
Perion Announces Filing of Annual Report on Form 20-F for Fiscal Year 2024
-
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
-
Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025
-
Arcus Biosciences Announces New Employment Inducement Grants
-
Aulos Bioscience to Present Promising Phase 2 Data for Novel IL-2 Therapeutic AU-007 in Melanoma at AACR Annual Meeting
-
Chimera Investment Corporation Sponsors Residential Mortgage Loan Securitizations
-
Panera Brands Names Paul Carbone Chief Executive Officer
-
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
-
Albany International Issues 2024 Sustainability Report
-
Compass Minerals Announces Cost Structure Reductions to Align With Current Business Needs
-
E2open to Report Fiscal 2025 Fourth Quarter and Full Year Results
-
Xylem to Release First Quarter 2025 Financial Results on April 29, 2025
-
Pebblebrook Hotel Trust Schedules First Quarter 2025 Earnings Release and Conference Call
-
TechnipFMC Awarded Major iEPCI™ Contract for Shell’s Gato do Mato Development Offshore Brazil
-
Faraday Technology Selects Silvaco FlexCAN IP for Advanced Automotive ASIC Design
-
NYSE Group Consolidated Short Interest Report
-
HealthWarehouse.com Reports Full Year 2024 Results
-
Levi Strauss & Co. to Webcast First Quarter 2025 Earnings Conference Call
-
One Equity Partners Agrees to Acquire CraftMark Bakery
-
University of Redlands’ Johnston Center Hosts International Green Industry Hall of Fame Event and Green Future Forum
-
2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results
-
Sitio Royalties Schedules First Quarter 2025 Earnings Call

